Tag: Pneumonia
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
Some Inflammatory Diseases Linked to Stroke-Associated Pneumonia
Risk for SAP reduced among patients with psoriasis, other chronic inflammatory diseases among acute ischemic stroke discharges
Crohn Disease, Comorbidities Up Risk for Severe Pneumococcal Disease
Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination
Cadmium Burden Linked to Mortality From Flu, Pneumonia
Risk for related mortality increased with urinary cadmium in the 80th versus the 20th percentile in whole population, never smokers in NHANES-III
Tocilizumab Cuts Progression to Ventilation or Death in COVID-19
But death from any cause by day 28 in those hospitalized with COVID-19 pneumonia did not differ for tocilizumab versus placebo
COVID-19 Outcomes Not Improved With Convalescent Plasma
Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia
High SARS-CoV-2 Genomic Load Tied to Worse Outcomes
Genomic load independent risk factor for composite outcome of death, intubation, ECMO
Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
